Variant report
Variant | nsv513125 |
---|---|
Chromosome Location | chr4:28420204-28422934 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs180957983 | chr4:28421008-28421009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs16880629 | chr4:28421017-28421018 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs560193728 | chr4:28421028-28421029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs570594883 | chr4:28421044-28421045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs185425289 | chr4:28421063-28421064 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs16880633 | chr4:28421064-28421065 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs188225965 | chr4:28421083-28421084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs542548594 | chr4:28421097-28421098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs144554871 | chr4:28421134-28421135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs572823979 | chr4:28421140-28421141 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs541618473 | chr4:28421263-28421264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs564705632 | chr4:28421316-28421317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs533583802 | chr4:28421338-28421339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs543479594 | chr4:28421359-28421360 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs563244590 | chr4:28421364-28421365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs114327131 | chr4:28421382-28421383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs139265019 | chr4:28421393-28421394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs565615076 | chr4:28421420-28421421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs142858515 | chr4:28421459-28421460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs6854479 | chr4:28421503-28421504 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs56011935 | chr4:28421508-28421509 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs570582519 | chr4:28421516-28421517 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs182057658 | chr4:28421549-28421550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs16880634 | chr4:28421565-28421566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs368590367 | chr4:28421590-28421591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs535839600 | chr4:28421592-28421593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs555826574 | chr4:28421749-28421750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs572762478 | chr4:28421772-28421773 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs541713143 | chr4:28421773-28421774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs146091021 | chr4:28421807-28421808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs578090395 | chr4:28421834-28421835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs543667502 | chr4:28421871-28421872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs563390361 | chr4:28421908-28421909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs367566202 | chr4:28421936-28421937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs372106915 | chr4:28421938-28421939 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs202017168 | chr4:28421939-28421940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs200198578 | chr4:28421940-28421941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs187174777 | chr4:28421968-28421969 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs191910042 | chr4:28421997-28421998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs542590757 | chr4:28422048-28422049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs549632083 | chr4:28422063-28422064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs183298638 | chr4:28422065-28422066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs528096165 | chr4:28422112-28422113 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs369594905 | chr4:28422144-28422145 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs533363889 | chr4:28422167-28422168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs113506385 | chr4:28422180-28422181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs530722510 | chr4:28422182-28422183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs561931781 | chr4:28422201-28422202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs140046194 | chr4:28422207-28422208 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs190206399 | chr4:28422223-28422224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Neuroblastoma | 18923191 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Lung cancer | 18438408 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 21183584 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:28421000-28421600 | Enhancers | Muscle Satellite Cultured Cells | -- |
2 | chr4:28421200-28421600 | Enhancers | Placenta Amnion | Placenta Amnion |
3 | chr4:28421600-28426000 | Weak transcription | Placenta Amnion | Placenta Amnion |